Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Petr Kysela"'
Autor:
Karolina Poredska, Lumir Kunovsky, Vladimir Prochazka, Jiri Dolina, Miroslava Chovancova, Jakub Vlazny, Tomas Andrasina, Michal Eid, Petr Jabandziev, Petr Kysela, Zdenek Kala
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-4 (2019)
Abstract Background Neurofibromatosis type-1 (NF1), also called von Recklinghausen disease, is a rare genetic disease which can lead to the development of benign or even malignant tumors. NF1 is mostly diagnosed in children or early adolescents who p
Externí odkaz:
https://doaj.org/article/9d38fc24c703493bb6d5d833cd8090d0
Autor:
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala, Radek Kroupa, Petr Kysela, Jiri Dolina, Jan Trna
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid malignancies with increasing incidence. The poor prognosis is due to the aggressive nature of the tumor, late detection, and the resistance to chemotherapy and radiotherapy. A ra
Externí odkaz:
https://doaj.org/article/32042d7da2c740b1a02eb870c12fc269
Autor:
Ondřej Slabý, Kateřina Nevědělová, Igor Kiss, Veronika Zubáňová, Zdeněk Kala, Zuzana Tylichová, Jana Nekvindová, Jan Vondráček, Alena Hyršlová Vaculová, Lucia Bohovicova, Pavel Fabian, Martin Krkoška, Petr Kysela, Jarmila Herůdková, Lenka Ostřížková, Vladimir Palicka, Lenka Radová
Publikováno v:
Pharmacological Reports. 74:148-158
Background Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in expression of several cytochrome P450 (CYP) family members that play a crucial role in bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab1f96a0b35b06fcaa5c5cbcaccc06c6
https://doi.org/10.1007/s43440-021-00338-9
https://doi.org/10.1007/s43440-021-00338-9
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 35(2)
Though the sixth most frequent malignancy, hepatocellular carcinoma (HCC) is the third most common cause of death amongst solid tumours. Only surgery in the early stages may provide the cure; however, HCC still has a high recurrence rate. Non-surgica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69793a91897d5ec2c419eb103d400220
https://pubmed.ncbi.nlm.nih.gov/35459334
https://pubmed.ncbi.nlm.nih.gov/35459334
Autor:
Martin, Krkoška, Jana, Nekvindová, Kateřina, Nevědělová, Veronika, Zubáňová, Lenka, Radová, Jan, Vondráček, Jarmila, Herůdková, Ondřej, Slabý, Igor, Kiss, Lucia, Bohovicová, Pavel, Fabian, Zuzana, Tylichová, Zdeněk, Kala, Petr, Kysela, Lenka, Ostřížková, Vladimír, Palička, Alena, Hyršlová Vaculová
Publikováno v:
Pharmacological reports : PR. 74(1)
Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in expression of several cytochrome P450 (CYP) family members that play a crucial role in biotransforma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82d113c113a681122841c68336745cd1
https://pubmed.ncbi.nlm.nih.gov/34780054
https://pubmed.ncbi.nlm.nih.gov/34780054
Autor:
J. Husty, J. Balko, Lumir Kunovsky, Petr Kysela, Zdenek Kala, Martina Farkašová, J. Vlazny, Vladimír Procházka, Michal Eid
Publikováno v:
Perspectives in Surgery. 100
Paragangliomy představuji skupinu neuroendokrinnich tumorů, ktere se vyskytuji v různých lokalizacich. Větsina jich produkuje katecholaminy, ktere se projevuji v pokrocilých stadiich typickými symptomy jako jsou bolesti hlavy, palpitace a hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843d5dfe3772bfc1d11e30de5b08beb9
https://doi.org/10.33699/pis.2021.100.3.138-142
https://doi.org/10.33699/pis.2021.100.3.138-142
Autor:
Michal Eid, Milan Dastych, Jakub Hustý, Roman Svaton, Lumír Kunovský, Petr Kysela, Zdeněk Kala, Oldrich Robek, Jakub Vlazny, Karolina Poredská
Publikováno v:
Vnitřní lékařství. 64:966-969
Maligni tumory tenkeho střeva tvoři jen asi 1-2 % ze vsech nadorů gastrointestinalniho traktu. Ackoli neuroendokrinni tumory (NETs) jsou relativně vzacne, tak i přesto představuji druhou nejcastějsi malignitu tenkeho střeva (hned po adenokarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc7baab483c02b726a2a4dd58f86ffdd
https://doi.org/10.36290/vnl.2018.135
https://doi.org/10.36290/vnl.2018.135
Autor:
Tomáš Andrašina, Karolina Poredská, Michal Eid, Vladimír Procházka, Lumir Kunovsky, Jakub Vlazny, Petr Jabandziev, Miroslava Chovancová, Zdenek Kala, Dolina J, Petr Kysela
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-4 (2019)
Diagnostic Pathology
Diagnostic Pathology
Background Neurofibromatosis type-1 (NF1), also called von Recklinghausen disease, is a rare genetic disease which can lead to the development of benign or even malignant tumors. NF1 is mostly diagnosed in children or early adolescents who present wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc4f11f0c37547d70263f37dd0c35b24
https://doi.org/10.1186/s13000-019-0848-7
https://doi.org/10.1186/s13000-019-0848-7
Autor:
Milan Dastych, Jiří Dolina, Jakub Hustý, Jakub Vlažný, Zdeněk Kala, Jan Trna, Lumír Kunovský, Karolina Poredská, Radek Kroupa, Roman Svatoň, Michal Eid, Petr Kysela
Publikováno v:
ESGE Days 2019.
Aims Primary malignant tumors of the small bowel constitute only about 1 – 2% of all gastrointestinal neoplasms. Although neuroendocrine tumors (NETs) are relatively rare, they still represent the second most common malignancy of the small bowel (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee37658551186a9ec6d4f034cd10c36
https://doi.org/10.1055/s-0039-1681914
https://doi.org/10.1055/s-0039-1681914
Autor:
Lumír, Kunovský, Milan, Dastych, Oldrich, Robek, Roman, Svaton, Jakub, Vlazny, Jakub, Hustý, Michal, Eid, Karolina, Poredska, Petr, Kysela, Zdeněk, Kala
Publikováno v:
Vnitrni lekarstvi. 64(10)
Primary malignant tumors of small bowel constitute only about 1-2% of all gastrointestinal neoplasms. Although neuroendocrine tumors (NETs) are relatively rare, they still represent the second most common malignancy of the small bowel (after adenocar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fe2c144a6f8fd603871d8e9953d273b
https://pubmed.ncbi.nlm.nih.gov/30590945
https://pubmed.ncbi.nlm.nih.gov/30590945